1. Home
  2. VYX vs HRMY Comparison

VYX vs HRMY Comparison

Compare VYX & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$6.96

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$28.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYX
HRMY
Founded
1881
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VYX
HRMY
Price
$6.96
$28.52
Analyst Decision
Strong Buy
Buy
Analyst Count
7
10
Target Price
$14.64
$46.70
AVG Volume (30 Days)
2.2M
1.1M
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
2.71
Revenue
N/A
$868,453,000.00
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$12.49
P/E Ratio
N/A
$10.56
Revenue Growth
N/A
21.51
52 Week Low
$6.46
$25.52
52 Week High
$14.67
$40.87

Technical Indicators

Market Signals
Indicator
VYX
HRMY
Relative Strength Index (RSI) 33.87 36.87
Support Level N/A $27.66
Resistance Level $11.17 $28.99
Average True Range (ATR) 0.44 0.87
MACD -0.07 0.19
Stochastic Oscillator 19.05 57.87

Price Performance

Historical Comparison
VYX
HRMY

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in three reportable segments: Retail, Restaurants, and Digital Banking. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The Digital Banking segment serves financial institutions with cloud-based software solutions for a fully integrated digital banking experience across channels. Revenue sources include software sales and service support within each segment.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: